Back to results
US 2015/0238630 A1Published application
Compositions and Methods for Antigen Targeting to CD180
AssigneeUniversity of Washington through its Center for Commercialization
InventorsEdward Clark, Jay Wesley Chaplin
Life of this patent
Estimating the term…
Abstract
The present limiting provides compositions of CD 180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.
Claims22
A composition, comprising:
- (a) an antibody or antibody fragment that binds CD180;
- and
- (b) a heterologous antigen attached to the antibody or antibody fragment that binds CD180.
-25. (canceled)
-29. (canceled)
Dependencies are inferred from the claim text.